As of Apr 20
| +0.05 / +1.58%|
The 1 analysts offering 12-month price forecasts for Female Health Co have a median target of 5.40, with a high estimate of 5.40 and a low estimate of 5.40. The median estimate represents a +68.22% increase from the last price of 3.21.
The current consensus among 1 polled investment analysts is to Buy stock in Female Health Co. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.